US Broker Ratings

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring an 85% Upside Potential in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, is capturing investor attention with its ambitious therapeutic innovations and a striking potential upside of 85.14%. This Miami-based..

Masimo Corporation (MASI) Stock Analysis: Evaluating the Growth Potential in the Medical Device Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specifically within medical devices, presents a compelling case for investors seeking exposure to innovative patient monitoring technologies. With a..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Growth Potential in a Competitive Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) is making waves in the healthcare sector with a market capitalization of $15.92 billion, underscoring its formidable presence in the diagnostics and research industry. Based..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating a 52-Week Low with Strategic Insights

Regencell Bioscience Holdings Limited (NASDAQ: RGC) has drawn attention with its current share price of $6.37, which sits at the lower end of its 52-week range ($6.09–$52.88). Despite its market..

Alkermes plc (ALKS) Stock Analysis: Navigating Growth in the Healthcare Sector Amidst Strong Revenue Performance

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, has been capturing investor interest with its robust revenue growth and diverse product portfolio. The company operates in the..

CVS Health Corporation (CVS): Analyst Ratings and Revenue Growth Unlock Investment Potential

Investors seeking a stable foothold in the healthcare sector need look no further than CVS Health Corporation (NYSE: CVS). As a dominant player in the healthcare plans industry, CVS Health..

Cigna Group (CI) Stock Analysis: Unpacking an 18% Upside Potential Amidst Strong Buy Ratings

The Cigna Group (NYSE: CI), a behemoth in the healthcare plans industry, continues to capture investor attention with its robust market presence and promising financial outlook. As a key player..

Chemed Corp (CHE) Stock Analysis: Navigating Growth in Healthcare with a Robust 25.60% Return on Equity

Chemed Corp (CHE), a stalwart in the healthcare sector, is making waves with its impressive return on equity (ROE) of 25.60%, setting it apart from many of its peers in..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and 19.64% Potential Upside in the Lucrative Medical Devices Sector

DexCom, Inc. (DXCM), a prominent player in the healthcare sector, particularly the medical devices industry, offers an enticing opportunity for investors with its robust growth potential and strong analyst support...

Qiagen N.V. (QGEN) Stock Analysis: Healthcare Innovator with a 9.63% Upside Potential

As an influential player in the Healthcare sector, Qiagen N.V. (NASDAQ: QGEN) is a noteworthy company for investors seeking exposure to the Diagnostics & Research industry. Based in the Netherlands,..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Exploring a 39% Potential Upside in the Biotech Arena

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is a prominent player in the biotechnology sector, renowned for its innovative approach to therapeutics based on ribonucleic acid interference (RNAi). With a market capitalization..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 21.25% Potential Upside in the Healthcare Sector

HealthEquity, Inc. (HQY) stands as a prominent player in the Health Information Services industry, nestled within the broader Healthcare sector. With a market capitalization of $7.97 billion, the company has..

Danaher Corporation (DHR) Stock Analysis: Promising 22% Upside Potential with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, operates at the intersection of diagnostics and research. With a substantial market capitalization of $140.09 billion, this American multinational continues..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Innovator with 36.10% Revenue Growth and Strategic Collaborations

Tempus AI, Inc. (NASDAQ: TEM), a dynamic player in the healthcare technology sector, is capturing investor attention with its strong revenue growth and strategic collaborations. Headquartered in Chicago, Illinois, this..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing Growth Potential with a 9.39% Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a current market capitalization of $34.55 billion, IQVIA..

Viatris Inc. (VTRS) Stock Analysis: Exploring the 6.66% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Viatris Inc. (VTRS) presents a compelling case for consideration. With a market capitalization of $19.45 billion, Viatris operates as a major player..

Tenet Healthcare Corporation (THC) Stock Analysis: A Healthcare Giant with a Promising 19.37% Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, is drawing investor attention with its strong market presence and compelling growth prospects. With a market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Biotechnology Giant Eyes Growth Despite Negative Earnings

Revolution Medicines, Inc. (NASDAQ: RVMD), a powerhouse in the biotechnology sector, continues to capture investor attention with its innovative approach to combating RAS-addicted cancers. The company, based in Redwood City,..

Cencora, Inc. (COR) Stock Analysis: Exploring an 18% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, commands a significant presence within the medical distribution industry. With a robust market cap of $57.69 billion, Cencora is..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Promising 91% Potential Upside in Cancer Therapy

For investors with a keen eye on the biotechnology sector, Legend Biotech Corporation (NASDAQ: LEGN) offers a compelling proposition, particularly with an impressive potential upside of 91.39%. As a significant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds